Mesa, Arizona, 85204, USA

Follow us :
Login
au

NANOPARTICLE FOR SUSTAIN RELEASE OF ACYCLOVIR INVITRO AND INVIVO DRUG COMPARTMENT MODELLING

Abstract

The main objective of this study was to organize the In-Vitro and In-Vivo correlation of immediate release Acyclovir tablets of 800 mg. In vitro and in vivo studies are done on the test product as Acyclovir Tablet USP 800 mg (containing Acyclovir 800 mg) of Cadila Medicinal Ltd., India versus Zovirax Tablet 800 mg (containing Acyclovir 800 mg) of GlaxoSmithKline, USA. In vivo studies are done in 36 healthy, adult, mortal subjects under fasting conditions. In vitro dissolution study was done using USP outfit II at 50 rpm in0.1 N HCL for 45 twinkles. The in vitro – in vivo interdependence of Acyclovir shows an R- squared value of0.9794 in the excel worksheet, which depicts a successful correlation between in vitro and in vivo characteristics of the medicine. In addition, PE AUC and PE C-max were planted to be –4.604 and-11.19 independently for each expression. The present study shows a good correlation between in vivo and in vitro PK biographies of the expression used as the test medicine in the study. (12)

Keywords
  • Acyclovir 800 mg tablets, In Vitro Dissolution, In Vivo absorption, IVIVC, C-max, cpk, pk
References

Authors

  • Mahendra Singh Kushwah Kushwah
    Affiliation:- a:1:{s:5:"en_US";s:113:"1Masters in Pharmaceutical Science from University Of Rajiv Gandhi Proudyogiki Vishwavidyalaya Bhopal (MP), India";}

How to Cite

Kushwah, M. S. K. (2021). NANOPARTICLE FOR SUSTAIN RELEASE OF ACYCLOVIR INVITRO AND INVIVO DRUG COMPARTMENT MODELLING. International Journal of Multidisciplinary Research and Studies, 4(11), 01–06. Retrieved from https://ijmras.com/index.php/ijmras/article/view/10

Download Citation


Downloads

Download data is not yet available.

Most read articles by the same author(s)